Literature DB >> 12728972

Sclerosing hemangioma of the lung: an analysis of 44 cases.

Kuang-Tai Kuo1, Wen-Hu Hsu, Yu-Chung Wu, Min-Hsiung Huang, Wing-Yin Li.   

Abstract

BACKGROUND: Sclerosing hemangioma is a rare benign lung tumor. Preoperative diagnosis of this tumor is difficult, and sometimes even intraoperative frozen sections cannot differentiate it from malignant tumors. Herein, we present our experiences in investigating its characteristics.
METHODS: The medical records and pathological examinations of patients diagnosed with sclerosing hemangioma from 1982 to 2001 at the Division of Thoracic Surgery in Taipei-VGH were retrospectively reviewed.
RESULTS: The incidence of sclerosing hemangioma in benign lung tumors resected during that period was 32.8%. There were 44 patients (7 male and 37 female) aged from 16 to 72 years, with a peak at fifth decade, and 72.7% of them were asymptomatic. Accurate preoperative diagnosis by chest CT could be achieved in only 20% (4/20) of patients, and malignancy could not be ruled out in 40% (8/20) of tumors. Histologically, this tumor exhibits four major patterns: solid, sclerotic, papillary and hemorrhagic. Five patients in this series had predominantly one pattern. At least two patterns existed in the remaining 39 patients, including eight patients who had tumors with all four patterns. There was no operative mortality or tumor recurrence despite that different operative methods were undertaken.
CONCLUSIONS: Although rare, sclerosing hemangioma still accounts for the second common benign lung tumor in the current series. Chest CT and bronchoscopic examinations could not make accurate diagnosis preoperatively, and thoracotomy is usually indicated for definite diagnosis and treatment. Limited resection is warranted in view of uncommon tumor recurrence. In addition, multiple nodular lesions could not exclude the possibility of sclerosing hemangioma.

Entities:  

Mesh:

Year:  2003        PMID: 12728972

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  9 in total

Review 1.  ["Pneumocytoma" or "sclerosing hemangioma": histogenetic aspects of a rare tumor of the lung].

Authors:  B M Einsfelder; K-M Müller
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

2.  Pulmonary sclerosing hemangioma with a rare symptom: A case report and review of the literature.

Authors:  Le Zhou; Chuntang Sun; Yan Huang; Qiao Li; Huairong Tang; Youjuan Wang
Journal:  Mol Clin Oncol       Date:  2016-12-21

3.  Pneumocytoma: a Case Report and Review of Literature.

Authors:  Rexeena Bhargavan; K Chandramohan; Arun Peter Mathew; Sindhu Nair
Journal:  Indian J Surg Oncol       Date:  2017-04-08

4.  Treatment of 28 patients with sclerosing hemangioma (SH) of the lung.

Authors:  Yang Lei; Duan Yong; Ruan Jun-Zhong; Yang Zhi; Wang Zi-Tong
Journal:  J Cardiothorac Surg       Date:  2012-06-18       Impact factor: 1.637

5.  Sclerosing pneumocytoma in a 1-year-old girl presenting with massive hemoptysis: A case report.

Authors:  Albaraa Bara; Ibrahim Adham; Obada Daaboul; Fatima Aldimirawi; Bassam Darwish; Lina Haffar
Journal:  Ann Med Surg (Lond)       Date:  2021-01-08

6.  Pulmonary Sclerosing Pneumocytoma: An Essential Differential Diagnosis for a Lung Nodule.

Authors:  Rajapriya Manickam; Ashesha Mechineni
Journal:  Cureus       Date:  2022-01-10

Review 7.  Pulmonary sclerosing pneumocytoma: clinical features and prognosis.

Authors:  Quan Zheng; Jian Zhou; Guangchen Li; Shulei Man; Zhangyu Lin; Tengyong Wang; Boran Chen; Feng Lin
Journal:  World J Surg Oncol       Date:  2022-04-30       Impact factor: 3.253

8.  Pulmonary sclerosing hemangioma: report of two cases.

Authors:  Chuang He; Hongyang Fang; Yun Liu; Xuequan Huang; Wei Zhen; Li Ren
Journal:  World J Surg Oncol       Date:  2012-09-03       Impact factor: 2.754

9.  Multiple peripheral typical carcinoid tumors of the lung: associated with sclerosing hemangiomas.

Authors:  Young Kim; Yoo-Duk Choi; Beum Jin Kim; In-Jae Oh; Sang-Yun Song; Jong-Hee Nam; Chang-Soo Park
Journal:  Diagn Pathol       Date:  2013-06-17       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.